HCPCS Level II code C1833 designates an implantable cardiac monitor that includes an intracardiac lead and all necessary system components. This device-level code matters nationally because implantable cardiac monitors are critical for long-term cardiac rhythm surveillance, management of arrhythmias, and guiding downstream clinical and procedural decisions. Accurate coding affects device tracking, hospital reimbursement for implantable device supplies, and payer adjudication.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for device use, typical sites of service where implantation occurs, and the payer landscape addressed. The publication provides benchmarks for coverage and reimbursement where available, common billing considerations tied to device implantation and supply coding, and a summary of policy or coding updates impacting claims for implantable cardiac monitoring systems. Where input data is missing, the document notes that specific items are not available in the input.